Clinical trials
Observational Lyme Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Unknown status | 4 |
| Terminated | 3 |
| Completed | 3 |
| Withdrawn | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 6 |
| Children's National Research Institute | 2 |
| ProgenaBiome | 2 |
| AI Agent Vault, Inc. d/b/a Precision Mito | 1 |
| Adaptive Biotechnologies | 1 |
| DiaSorin Inc. | 1 |
| Dr. Daniel Cameron & Associates | 1 |
| FlightPath Biosciences, Inc. | 1 |
| MicroB-plex, Inc. | 1 |
| Oxford Immunotec | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lyme Disease | 21 |
| Post-Lyme Disease Syndrome | 5 |
| Tick-Borne Diseases | 4 |
| Arthritis, Rheumatoid | 3 |
| Glossitis, Benign Migratory | 3 |
| Amyotrophic Lateral Sclerosis | 2 |
| Anxiety Disorders | 2 |
| Colitis, Ulcerative | 2 |
| Colonic Neoplasms | 2 |
| Crohn Disease | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.